GO
Loading...

Sudden Death

Savient Pharmaceuticals : "I still like it as much as I did at the beginning of the year ... I'm not backing away."

BioMarin Pharmaceutical : "I like [it]. I know people were disappointed with that last quarter. I think it's a mistake. BioMarin's a good biotech stock - and a takeover target."

MetroPCS Communications : "Let's not be too greedy. That stock has had a run." Cramer likes AT&T in this sector.

Questions? Comments? madmoney@cnbc.com

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.

Mad Money Moments

Cramer's New Book